As of November 2024, Mabpharm has a market cap of $161.40M. This makes Mabpharm the world's 18607th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $248.71M | 2.17% |
2023 | $243.42M | 5.75% |
2022 | $230.19M | -56.50% |
2021 | $529.17M | -4.76% |
2020 | $555.63M | -8.70% |
2019 | $608.54M | - |